Patents by Inventor Amy K. W. Lasek

Amy K. W. Lasek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7105315
    Abstract: The invention provides a transmembrane protein that is differentially expressed in neoplastic disorders. It also provides for the use of the protein, a cDNA encoding the protein, and antibodies that specifically bind the protein in various methods to diagnose, stage, treat, or monitor the treatment of a neoplastic disorder.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: September 12, 2006
    Assignee: Incyte Genomics, Inc.
    Inventors: Amy K. W. Lasek, Mariah R. Baughn, Yalda Azimzai
  • Publication number: 20040214990
    Abstract: The invention provides a transmembrane protein, TMDC, that is differentially expressed in a colon or stomach cancer. It also provides for the use of the protein, a cDNA encoding the protein, and antibodies that specifically bind the protein in various methods to diagnose, stage, treat, or monitor the progression or treatment of a colon or stomach cancer.
    Type: Application
    Filed: February 24, 2004
    Publication date: October 28, 2004
    Inventors: Catherine M. Tribouley, Amy K W Lasek, Henry Yue, Mariah R. Baughn
  • Publication number: 20030175704
    Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in respiratory disorders and which may be used in their entirety or in part to diagnose, to stage, to treat, or to monitor the treatment of a subject with a respiratory disorder including lung cancer, chronic obstructive pulmonary disease, emphysema, and asthma.
    Type: Application
    Filed: October 4, 2001
    Publication date: September 18, 2003
    Inventors: Amy K. W. Lasek, Andrew W. Shyjan, Christopher M. Turner
  • Publication number: 20030073105
    Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in colon cancer and which may be used in their entirety or in part as to diagnose, to stage to treat or to monitor the progression or treatment of colon cancer.
    Type: Application
    Filed: May 29, 2002
    Publication date: April 17, 2003
    Inventors: Amy K.W. Lasek, Thierry Sornasse
  • Publication number: 20030068311
    Abstract: The invention provides a transmembrane protein that is differentially expressed in neoplastic disorders. It also provides for the use of the protein, a cDNA encoding the protein, and antibodies that specifically bind the protein in various methods to diagnose, stage, treat, or monitor the treatment of a neoplastic disorder.
    Type: Application
    Filed: July 1, 2002
    Publication date: April 10, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Amy K. W. Lasek, Mariah R. Baughn, Yalda Azimzai
  • Publication number: 20030013099
    Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed by DNA methylation in tumor cells and which may be used in their entirety or in part to diagnose, to stage, to treat, or to monitor the treatment of a subject with a disorder such as cancer.
    Type: Application
    Filed: March 7, 2002
    Publication date: January 16, 2003
    Inventors: Amy K. W. Lasek, David A. Jones, Adam R. Karpf